ARS Pharmaceuticals Inc (SPRY) USD 0.0001
Sell:$10.89Buy:$11.35
$0.08
(0.74%)
- This stock can be held in a
Stocks and Shares ISA$0.08
(0.74%)$0.08
(0.74%)Company Information
About this company
ARS Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing neffy, for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, administered and nasal spray. Type I allergic reactions are potentially life-threatening hypersensitivity reactions that can occur within minutes of exposure to an allergen and need to be treated immediately to relieve symptoms and prevent further progression.
Key people
Key facts
- EPICSPRY
- LocationUnited States
- SectorHealthcare
- IndustryBiotechnology & Drugs
- ISINUS82835W1080
- Market cap$1.02bn
- Employees146
- Shares in issue97.19m
- ExchangeNASDAQ
- IndexTR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.